Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Purethal SCIT in Elderly Patients With Grass Pollen Allergy
NCT02440243Phase 4Completed
- Sponsor
- Medical University of Silesia
- Start
- Jan 2011
- Primary completion
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes, Therapeutic Vaccines
01
Overview
A Phase 4 trial of Purethal in seasonal allergic rhinitis (SAR), sponsored by Medical University of Silesia. Started Jan 2011; status: completed.
02
Drugs
Purethal
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT02440243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02440243.